Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2011 (2011), Article ID 173035, 7 pages
http://dx.doi.org/10.1155/2011/173035
Research Article

Dexamethasone Treatment Reverses Cognitive Impairment but Increases Brain Oxidative Stress in Rats Submitted to Pneumococcal Meningitis

1Laboratory of Experimental Microbiology and National Institute for Translational Medicine (INCT-TM), Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
2Laboratory of Pathophysiology and National Institute for Translational Medicine (INCT-TM), Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
3Laboratory of Neurosciences and National Institute for Translational Medicine (INCT-TM), Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil

Received 7 February 2011; Revised 26 August 2011; Accepted 7 September 2011

Academic Editor: Ersin Fadillioglu

Copyright © 2011 Tatiana Barichello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. T. Brandt, “Experimental studies of pneumococcal meningitis,” Danish Medical Bulletin, vol. 57, no. 1, p. B4119, 2010. View at Google Scholar · View at Scopus
  2. D. van de Beek, D. B. Schmand, J. de Gans et al., “Cognitive impairment in adults with good recovery after bacterial meningitis,” Journal of Infectious Diseases, vol. 186, no. 7, pp. 1047–1052, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Nau, A. Soto, and W. Brück, “Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis,” Journal of Neuropathology and Experimental Neurology, vol. 58, no. 3, pp. 265–274, 1999. View at Google Scholar
  4. D. van de Beek, “Corticosteroids for acute adult bacterial meningitis,” Medecine et Maladies Infectieuses, vol. 39, no. 7-8, pp. 531–538, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. S. Leib and G. M. Tauber, “Pathogenisis of bacterial meningitis,” Infectious Disease Clinics of North America, vol. 13, no. 3, pp. 527–548, 1999. View at Google Scholar
  6. B. R. Nathan and M. W. Scheld, “New advances in the pathogenesis and pathophysiology of bacterial meningitis,” Current Infectious Disease Reports, vol. 2, no. 4, pp. 332–336, 2000. View at Publisher · View at Google Scholar
  7. G. Cohen, “Oxygen radicals and Parkinson's disease,” in Oxygen Radical and Tissue Injury, B. Halliwell, Ed., pp. 130–135, Federation of American Societies for Experimental Biology, Bethesda, Md, USA, 1988. View at Google Scholar
  8. R. A. Floyd, “Antioxidants, oxidative stress, and degenerative neurological disorders,” Proceedings of the Society for Experimental Biology and Medicine, vol. 222, no. 3, pp. 236–245, 1999. View at Google Scholar · View at Scopus
  9. S. Christen, M. Schaper, J. Lykkesfeldt et al., “Oxidative stress in brain during experimental bacterial meningitis: differential effects of α-phenyl-tert-butyl nitrone and N-acetylcysteine treatment,” Free Radical Biology and Medicine, vol. 31, no. 6, pp. 754–762, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Kastenbauer and H. W. Pfister, “Protection against meningitis-associated central nervous system complications by uric acid,” Medical Hypotheses, vol. 58, no. 5, p. 431, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. F. A. Rucián, G. G. D. Cerro, F. C. Usandizaga, M. T. Rué, X. Martínez Gómez, and F. A. Moraga-Llop, “Treatment of pneumococcal meningitis with dexamethasone,” Anales de Pediatria, vol. 74, no. 1, pp. 38–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Liu, Q. Han, R. Sun, and Z. Li, “Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis,” Brain Research, vol. 1207, pp. 237–243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Irazuzta, R. K. Pretzlaff, G. de Courten-Myers, F. Zemlan, and B. Zingarelli, “Dexamethasone decreases neurological sequelae and caspase activity,” Intensive Care Medicine, vol. 31, no. 1, pp. 146–150, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Irazuzta, K. Robert, and K. R. Pretzlaff, “Caspases inhibition decreases neurological sequelae in meningitis,” Critical Care Medicine, vol. 36, no. 5, pp. 1603–1606, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. L. Leib, C. Heimgartner, Y. D. Bifrare, J. M. Loeffler, and M. G. Täuber, “Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats,” Pediatric Research, vol. 54, no. 3, pp. 353–357, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. R. S. Coimbra, G. Loquet, and S. L. Leib, “Limited efficacy of adjuvant therapy with dexamethasone in preventing hearing loss due to experimental pneumococcal meningitis in the infant rat,” Pediatric Research, vol. 62, no. 3, pp. 291–294, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. E. Irazuzta, R. K. Pretzlaff, B. Zingarelli, V. Xue, and F. Zemlan, “Modulation of nuclear factor-κB activation and decreased markers of neurological injury associated with hypothermic therapy in experimental bacterial meningitis,” Critical Care Medicine, vol. 30, no. 11, pp. 2553–2559, 2002. View at Google Scholar · View at Scopus
  18. D. Grandgirard, O. Steiner, M. G. Täuber, and S. L. Leib, “An infant mouse model of brain damage in pneumococcal meningitis,” Acta Neuropathologica, vol. 114, no. 6, pp. 609–617, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. E. Irazuzta, G. de Courten-Myers, F. P. Zemlan, M. Y. V. Bekkedal, and J. Rossi, “Serum cleaved Tau protein and neurobehavioral battery of tests as markers of brain injury in experimental bacterial meningitis,” Brain Research, vol. 913, no. 1, pp. 95–105, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Barichello, I. dos Santos, G. D. Savi et al., “Tumor necrosis factor α (TNF-α) levels in the brain and cerebrospinal fluid after meningitis induced by Streptococcus pneumoniae,” Neuroscience Letters, vol. 467, no. 3, pp. 217–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Grandgirard, C. Schürch, P. Cottagnoud, and S. L. Leib, “Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 6, pp. 2173–2178, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. O. J. Cassol-Jr, C. M. Comim, F. Petronilho et al., “Low dose dexamethasone reverses depressive-like parameters and memory impairment in rats submitted to sepsis,” Neuroscience Letters, vol. 473, no. 2, pp. 126–130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Barichello, G. Z. Silva, J. S. Generoso et al., “Time-dependent behavioral recovery after pneumococcal meningitis in rats,” Journal of Neural Transmission, vol. 117, no. 7, pp. 819–826, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Esterbauer and K. H. Cheeseman, “Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal,” Methods in Enzymology, vol. 186, pp. 407–421, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. R. L. Levine, J. A. Williams, E. R. Stadtman, and E. Shacter, “Carbonyl assays for determination of oxidatively modified proteins,” Methods in Enzymology, vol. 233, pp. 346–357, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  27. P. W. Riddles, R. L. Blakeley, and B. Zerner, “Reassessment of Ellman's reagent,” Methods in Enzymology, vol. 91, pp. 49–60, 1983. View at Publisher · View at Google Scholar · View at Scopus
  28. J. J. Poderoso, M. C. Carreras, C. Lisdero, N. Riobó, F. Schöpfer, and A. Boveris, “Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles,” Archives of Biochemistry and Biophysics, vol. 328, no. 1, pp. 85–92, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. R. A. Hirst, A. Kadioglu, C. O'Callaghan, and P. W. Andrew, “The role of pneumolysin in pneumococcal pneumonia and meningitis,” Clinical and Experimental Immunology, vol. 138, no. 2, pp. 195–201, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Klein, U. Koedel, and H. W. Pfister, “Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy?” Progress in Neurobiology, vol. 80, no. 6, pp. 269–280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Sellner, M. G. Täuber, and S. L. Leib, “Pathogenesis and pathophysiology of bacterial CNS infections,” Handbook of Clinical Neurology, vol. 96, pp. 1–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. G. Tauber, H. Khayam-Bashi, and M. A. Sande, “Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis,” Journal of Infectious Diseases, vol. 151, no. 3, pp. 528–534, 1985. View at Google Scholar · View at Scopus
  33. D. van de Beek, J. de Gans, P. McIntyre, and K. Prasad, “Steroids in adults with acute bacterial meningitis: a systematic review,” Lancet Infectious Diseases, vol. 4, no. 3, pp. 139–143, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. C. M. Odio, I. Faingezicht, M. Paris et al., “The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis,” New England Journal of Medicine, vol. 324, no. 22, pp. 1525–1531, 1991. View at Google Scholar · View at Scopus
  35. D. van de Beek, J. de Gans, P. McIntyre, and K. Prasad, “Corticosteroids for acute bacterial meningitis,” Cochrane Database of Systematic Reviews, vol. 24, no. 1, p. 4405, 2007. View at Google Scholar · View at Scopus
  36. J. de Gans and D. van de Beek, “European: dexamethasone in adulthood bacterial meningitis study investigators. Dexamethasone in adults with bacterial meningitis,” The New England Journal of Medicine, vol. 347, no. 20, pp. 1549–1556, 2002. View at Google Scholar
  37. D. van de Beek, J. J. Farrar, J. de Gans et al., “Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data,” The Lancet Neurology, vol. 9, no. 3, pp. 254–263, 2010. View at Publisher · View at Google Scholar · View at Scopus